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CHAPTER I 
 
 
INTRODUCTION 
Cardiovascular disease (CVD) has been defined as hypertension, coronary heart disease 
(CHD), which includes myocardial infarction (MI) and angina pectoris, heart failure, stroke, 
and/or congenial cardiovascular defects (1). An estimated 82.6 million people, approximately one 
in three American adults, have at least one form of CVD: high blood pressure (76.4 million), 
CHD (16.3 million), myocardial infarction (7.9 million), angina pectoris (9 million), heart failure 
(5.7 million), stroke (7 million), and congenital cardiovascular defects (650,000-1.3 million) (2). 
The incidence of cardiovascular events is affected by gender and age. Older men and 
women have higher incident rates than younger people of the same gender. In addition, women 
have a lower incidence rate than men of similar ages. The incidences of CVD in men are 3.3, 
10.1, 21.4, and 34.6 per 1000 men for ages 35-44, 45-54, 55-64, and 65-74, respectively (3). The 
incidences of CVD in women are 1.2, 4.2, 8.9, and 20.0 per 1000 women for ages 35-44, 45-54, 
55-64, and 65-74 respectively (3). This suggests that men at any given age are approximately 2 
times more likely to have CVD than women of a similar age range. 
In the United States, CVD as an underlying cause of death accounted for 33.6% of deaths 
in 2007 (2). In 2007, CVD claimed 813,804 lives (2). CVD death rates were 300.3 and 211.6 for 
men and women, respectively (2). Heart disease killed more Americans than cancer, chronic 
lower respiratory disease, and accidents combined, making it the leading cause of death for 
2 
 
elderly men and women in 2007 (2). Approximately 33% of deaths attributed to CVD occurred 
before the age of 75 years, which was below the average life expectancy of 77.9 years (2). 
Epidemiological studies have found an association between increased consumption of 
fruits and vegetables and decreased risk of cardiovascular disease and all cause mortality (4, 5). 
Studies on specific fruits and vegetables attempt to isolate the bioactive component(s) that are 
responsible for the cardio-protective properties of fruits and vegetables. Fruits, such as berries, 
have been increasingly studied for their high concentration of fiber and antioxidant vitamins such 
as vitamins E and C, as well as their rich source of polyphenols (6, 7). The polyphenol, 
anthocyanins and anthocyanidins, rich in strawberries, have been associated with reduced risk of 
death all-cause CVD and certain CVD metabolic risk factors (8, 9). 
The goal of the study is to investigate the effects of freeze-dried strawberries in metabolic 
risk factors for CVD in a randomized clinical trial. Parameters that were assessed are lipid profile, 
glucose metabolism, and markers of oxidative stress in subjects with dyslipidemia and abdominal 
adiposity versus age-gendered matched control at baseline, 6 and 12 weeks after strawberry 
supplementation. 
The specific aims are to: 
1. Investigate the effects of freeze-dried strawberries on anthropometric measures and blood 
pressure 
2. Investigate the effects of freeze-dried strawberries on glucose, insulin, lipid profile, and 
markers of lipid oxidation (oxidized-LDL and malonaldehyde) 
The null hypotheses are that: 
• Freeze-dried strawberry supplementation will have no effects on anthropometric 
measures and blood pressure compared to control 
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• Freeze-dried strawberry supplementation will have no effects on glucose, insulin, lipid 
profile, and markers of lipid oxidation compared to control 
• Freeze-dried strawberry supplementation will not affect safety parameters such as, liver 
and kidney function tests and blood cell count in subjects versus controls
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CHAPTER II 
 
 
CARDIOVASCULAR DISEASE & OBESITY IN THE UNITED STATES 
Cardiovascular disease (CVD) has been a major cause of death in the United States for 
the last hundred years. Each year, cardiovascular disease kills more Americans than cancer, 
chronic respiratory disease, and accidents combined (10). In 2006, cardiovascular disease was the 
underlying cause of death for 831,272 lives, which accounts for 34.3% of deaths (1). An 
estimated 81.1 million people, approximately one in three American adults, have at least one 
form of cardiovascular disease (1). Forms of CVD are defined as hypertension, coronary heart 
disease (CHD), heart failure, stroke, or congenial cardiovascular defects (1). As a result of health 
care services, medications, and loss of productivity, heart disease will cost the United States 
$316.4 billion (1). 
OBESITY 
Obesity has become an epidemic in the United States, where even children and 
adolescents are increasingly becoming overweight or obese. Nearly ten million children and 
adolescents ages six to nineteen are at or above the 95th percentile on the CDC growth charts for 
the United States for BMI-for-age (11). Adolescents who are overweight have been found to have 
a 70% chance of becoming overweight adults (1). If the United States continues with the current 
trend, by 2030, approximately 86% of adults will be overweight or obese (1). As a result, the 
estimated total health care costs for obesity could reach $861 to 957 billion, in 2030, which will 
account for 16-18% of US health expenditures (1). 
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Overweight and obesity is associated with increased risk of diseases and chronic 
conditions, such as CVD (12). Overweight individuals were 20% and 21% more likely to develop 
cardiovascular disease than normal-weight persons for women and men, respectively (12). 
Obesity increases the risk of developing cardiovascular disease by 64% and 46% in women and 
men, respectively (12). Being overweight was not found to be associated with increased mortality 
due to cardiovascular disease; however, being obese is associated with a significant increase in 
morality due to cardiovascular disease (12). In 2004, obesity was associated with 13% of 
cardiovascular disease deaths (13). Overweight and obesity are also associated with decreases in 
life expectancy (14). 
In the 26 year cohort, the Framingham Heart Study studied the association of weight and 
cardiovascular disease. The 2252 men and 2818 women ages 28-62 were free of clinically 
recognizable cardiovascular disease upon entry and 18.9% and 20.5% were overweight in men 
and women, respectively. This study found obesity is an independent risk factor for 
cardiovascular disease (15). The association of weight and cardiovascular incidence was more 
pronounced in subjects younger than 50 years of age. When comparing the self reported weight of 
subjects at 25 years of age compared to entry, subjects who gained weight were associated with 
an increased risk of disease regardless of their obesity index. On the flip side, subjects who lost 
weight were associated with a decreased risk of disease. This implied that weight loss at any body 
mass index (BMI) may be beneficial to reducing risk for CVD. One of the most profound effects 
obesity has on cardiovascular health is that ≥75% of hypertension can be directly attributed to 
obesity (16). Other effects obesity has on cardiovascular health are the increased levels of 
triglycerides, elevated low density lipoprotein-cholesterol (LDL-C), and low high density 
lipoprotein-cholesterol (HDL-C) (16). 
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 According to the Centers for Disease Control and Prevention (CDC), adults are 
categorized as obese when they have a body mass index (BMI) of 30 or higher. However, BMI 
often fails to differentiate between different body compositions; therefore, more effective ways in 
estimating body fat is by measuring skin-fold thickness and waist circumference. Differentiating 
persons with similar BMI but different body compositions is important because excess abdominal 
fat is associated with an increased risk of metabolic risk factors. Currently, waist circumference is 
considered the most effective diagnosis of obesity (17). 
In obese individuals who are similar weight, more abdominal adipose tissue is related to 
increased metabolic abnormalities (18). Even in non-obese individuals, abdominal adiposity has 
been associated with increased risk of cardiovascular disease. In a case-control study of healthy 
subjects matched for BMI and age, subjects (n=350) with a waist-to-hip ratio ≥0.9 in males and 
≥0.85 in females have significantly higher high sensitive C-reactive protein (hs-CRP) (1.96 ± 
2.60 vs. 1.53 ± 1.74 mg/dl; P <0.01) levels compared to control (waist-to-hip ratio <0.9 in males 
and <0.85 in females, n=199) (19). Similarly, Lapice et al. (2009) found that subjects with 
visceral adiposity are approximately two times more likely to have CRP >3mg/dl and metabolic 
syndrome (P<0.01). High sensitive CRP and CRP are acute inflammatory proteins. Inflammation 
can lead to CVD through the progression and exacerbation of atherosclerosis, which is the fatty 
deposit build up in the artery walls (20). This suggested that abdominal adiposity may lead to an 
increased risk of CVD possibly through increasing systemic acute-phase inflammatory proteins. 
Hs-CRP plasma levels may be more indicative of cardiovascular disease risk in individuals who 
have low risk factors typical of cardiovascular disease (20). This is especially important since 
total cholesterol levels >200 mg/dL does not account for 35% of people with coronary heart 
disease (21). Therefore, this suggests that measuring abdominal adiposity may be a low cost tool 
with a strong correlation in identifying individuals at risk for cardiovascular disease, especially 
those who do not have elevated cholesterol levels. 
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HYPERTENSION 
 Hypertension is defined as blood pressure ≥140 mmHg/ ≥90 mmHg, taking 
antihypertensive medication(s), or being told by a physician or health care professional at least 
twice that one has high blood pressure. An estimated 74.5 million adults over the age of 20 have 
high blood pressure (10). In 2006, the mortality of high blood pressure is 56,561 lives (22). In 
addition, high blood pressure was associated with shorter life expectancy and increased years a 
person lived with CVD (23). The total life expectancy of persons with high blood pressure is 5.1 
and 4.9 years shorter than persons with normal blood pressure for men and women, respectively 
(23). At age 50, men with untreated high blood pressure lived 7.2 years shorter than men who 
lowered their blood pressure below 140/90 mmHg (23). In addition, those men who lowered their 
blood pressure also lived fewer years with CVD (23). Although hypertension have mostly been 
associated with men, the National Health and Nutrition Examination Survey (NHANES) found 
that gender differences between rates of hypertension are also age dependent (1). Men have 
higher rates of hypertension than women until the age of 45. From ages 45 to 64, men and women 
have the same rates of hypertension. And after age 64, women have a higher percentage of 
hypertension than men. 
DYSLIPIDEMIA AND ATHEROSCLEROSIS 
 Dyslipidemia is an increased level of circulating blood lipids: high levels of total 
cholesterol, low density lipoprotein (LDL), and triglycerides as well as low levels of high density 
lipoprotein (HDL). High blood cholesterol and lipids have been associated with the increase risk 
of heart disease, particularly CHD. In 2006, 16.2% of adults ≥20 years of age have total serum 
cholesterol levels ≥240 mg/dL (24). That is an estimated 35.7 million adults with high blood 
cholesterol levels. The Centers for Disease Control predicted that if there is a 10% population-
wide decrease in total cholesterol levels, there will be an estimated 30% decrease in CHD 
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incidences (24). High levels of LDL cholesterol, also commonly referred as “bad” cholesterol, are 
usually associated with plaque buildup in arteries, which leads to an increased risk of developing 
heart disease. In 1999-2004, the age-adjusted prevalence of high LDL cholesterol in the US adults 
is 25.3% (25). HDL cholesterol, on the other hand, is known as “good” cholesterol and low levels 
levels (≤40 mg/dL) are considered a risk factor for heart disease and stroke. American adults ≥20 
years of age have the mean level of HDL cholesterol of 54.3 mg/dL (NHANES 2003-2006, 
NCHS and NHLBI; unpublished analysis). The mean level of triglyceride level in American 
adults ≥20 years of age is 144.2 mg/dL (NHANES 2003-2006, NCHS and NHLBI; unpublished 
analysis). Triglyceride levels >150 mg/dL is considered a risk factor for heart disease and stroke. 
When the triglyceride levels are stratified by gender, the mean level for men is 156.5 mg/dL and 
for women it is 132.1 mg/dL. 
High circulating levels of free fatty acids can lead to atherosclerosis (26). Free fatty acids 
increases ROS formation, which upregulates inflammatory cytokines, such as C-reactive protein 
(CRP) and tumor necrosis factor-α (TNF-α). Inflammatory cytokines increases the translation or 
synthesis of endothelial adhesion molecules, such as intracellular adhesion molecules (ICAM) or 
vascular cell adhesion molecules (VCAM). Increased ICAM and VCAM on endothelial cells will 
induce monocyte adhesion, which initiates atherosclerosis. Macrophages, which are matured 
monocytes, engulf oxidized-low density lipoprotein (ox-LDL) to mature into foam cells. Ox-LDL 
also increases VCAM molecules, which further exacerbates the atherosclerotic process. 
 Lipids under increased oxidative stress and the concentration of metals (i.e. iron) can 
form lipid radicals (26, 27). Increased lipid radicals, such as ox-LDL can further mature 
macrophages and upregulate initiation of atherosclerosis. Lipid peroxidation products are also 
extremely toxic. Lipids can oxidize to form lipid alkoxyl radicals (LO•) or peroxyl radicals 
(LOO•) (27). Alkoxyl radicals and peroxyl radicals go through cyclisation to yield 4, 
hydroxynonenal (HNE) and malondialdehyde (MDA), respectively. HNE and MDA are both 
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extremely toxic products which cause DNA damage (27). HNE can affect signal transduction 
pathways, which can affect cell morphology and biochemical and physiological properties. MDA 
can disrupt DNA by reacting with DNA bases, forming adducts. HNE and MDA are frequently 
used to assess disease states such as cardiovascular disease, atherosclerosis, and cancer. 
 Hypercholesterolemia had been associated with vascular dysfunction, inflammation, and 
oxidative stress. Hypercholesterolemia has been associated with the inhibition of nitric oxide 
(NO) production, which is important in the regulation of vascular tone, prevention of platelet 
activation, inhibition of oxidative stress, cell growth, and inflammation (28). An inflammatory 
response catalyzed by increased circulating cholesterol or triglycerides leads to the progression of 
atherosclerosis through increased cell adhesion molecules, leukocyte recruitment, and rolling and 
adherence of the monocyte (28). Hypercholesterolemia has been associated with increased 
oxidative stress by the increased reactive oxygen species (ROS) through three major enzyme 
systems: NADPH oxidase (NOX), xanthine oxidase, and myeloperoxidase (28). Therefore, 
hypercholesterolemia is a major contributor to CVD by the dysfunction of the vascular 
endothelium, increase in inflammation and oxidative stress. 
INSULIN RESISTANCE AND IMPAIRED FASTING GLUCOSE 
 Insulin resistance results in impaired glucose metabolism which elevates glucose 
concentrations above levels classified as normal, but does not elevate glucose concentrations to 
levels classified as diabetes mellitus (DM). Insulin resistance is the body’s inability to effectively 
use insulin that is produced. Since insulin is a hormone required for the uptake of glucose to the 
cell, insulin resistance frequently results in elevated plasma glucose concentrations. Elevated 
fasting glucose levels of 100-125 mg/dL are classified as impaired fasting glucose or pre-diabetes 
(29). Impaired fasting glucose is fasting glucose levels above normal, but does not qualify as 
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clinical DM. Prolonged hyperglycemia have been found to increase risk of atherosclerosis by 
increasing ROS formation through various pathways (26).  
 In a Danish prospective study, Jeppesen et al. (2007) studied whether or not insulin 
resistance was a risk factor for CVD independent of metabolic syndrome. This study followed 
2493 men and women, who were free of major CVD at baseline, for an average of 9.4 years. 
CVD endpoints were defined as cardiovascular death, nonfatal ischemic heart disease, and 
nonfatal stroke. Insulin resistance was found to be an independent predictor of CVD (30). In 
addition, insulin resistance was found to increase the relative risk of CVD by 67%. This 
suggested that although impairment of glucose metabolism may not reach clinical levels, it may 
still have profound effects on the biological system, specifically to the cardiovascular system.  
OTHER CARDIOVASCULAR DISEASE RISK FACTORS 
 Several other factors associated with increased cardiovascular disease incidence include 
age, race, income, and occupational status. According to the 2003 Centers for Disease Control 
and Prevention Behavioral Risk Factor Surveillance System (CDC BRFSS) survey of adults ≥18 
years of age, the prevalence of having ≥2 risk factors is highest amongst adults who reported 
being unable to work (69.3%). Second highest is amongst persons reporting household income of 
≤ $10,000 (52.5%) (31). The next two indicators with the highest prevalence of cardiovascular 
disease risk factor is race. Blacks have a prevalence of 48.7% and American Indians/Alaska 
Natives have a prevalence of 46.7%. Other prominent indicators of risk factors include 
state/territory, the highest prevalence being persons living in Kentucky (46.2%). There are also 
twelve states and two territories that have multiple risk factor prevalence of ≥40%: Alabama, 
Arkansas, Georgia, Indiana, Kentucky, Louisiana, Mississippi, North Carolina, Ohio, Oklahoma, 
Tennessee, West Virginia, Guam, and Puerto Rico.  
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FRUIT & VEGETABLE INTAKE IN THE UNITED STATES 
 The current dietary consumption of US adults ≥20 years old is limited to nutrient dense 
foods. The average fruit consumption is 1.1-1.8 servings/day across all race and gender groups 
with 5.8-11% meeting the guidelines of ≥4 servings/day. When 100% fruit juices are included, 
fruit consumption increases to 2-2.8 servings/day and 13.8-23.7% meeting the guidelines for fruit 
consumption. This may be of interest for intervention since most adult Americans are not eating 
enough whole fruits but almost double their intake if fruits are consumed in the form of a 
beverage. The average consumption of vegetables is 1.2-2.1 servings; 11-14% of whites, 5-10% 
of blacks, and 3-5% of Mexican Americans consume the recommended amount of ≥5 
serving/day. Fruits and vegetables are a major source of dietary fiber and a large portion of the 
US adult population are not meeting recommended levels. Only 3-7% of whites, 2-3% of blacks, 
and 11-12% of Mexican Americans are consuming ≥28 g of dietary fiber/day. Diets high in fiber 
can help lower blood cholesterol which may lower risk of cardiovascular disease (32). 
Diets high in fruits and vegetables have been found to be associated with lower risk of 
CVD morbidity and mortality (4, 5, 33). In prospective studies by Hung et al. (2004), fruit and 
vegetables were associated with a moderately significant decrease in chronic diseases (p=0.07) in 
healthy health professionals. However, further analyses indicated that the positive effects of fruits 
and vegetables were most significantly associated with a decrease risk in CVD, but were not 
found to be significantly associated with incidence of cancer. Similarly, Liu et al. (2000) found 
that increasing quintiles of fruit and vegetable intake were significantly associated with decreased 
incidence of CVD in healthy, female health professionals. Fruit and vegetable intake greater than 
5 servings per day was significantly associated with a 12-32% decrease in CVD incidence (4, 33). 
Furthermore, increasing consumption of fruits and vegetables was associated with a greater and 
more significant reduction in relative risk of MI ranging from 43-61% (4). In addition, reduced 
risk of CVD and MI with increasing quintiles of fruit consumption was associated with a greater 
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and more significant reduction in CVD and MI compared to total fruits and vegetables and 
vegetables alone. Lastly, fruit and vegetable intake was found to be associated with reduced 
relative risks of CVD, specific CVD incidence, and total mortality (5). In the prospective cohort 
study by Bazzano et al. (2002), healthy subjects who consume fruits and vegetables greater than 3 
times per day were found to have significantly lower risks of stroke, stroke mortality, ischemic 
heart disease, ischemic heart disease mortality, cardiovascular disease mortality, 
noncardiovascular disease mortality, and all-cause mortality (p<0.02). However, after 
multivariate adjustment, ischemic heart disease and noncardiovascular disease mortality were no 
longer found to be significant (p>0.05) and ischemic heart disease mortality was only moderately 
significant (p=0.07). There is suggestion that different fruits and vegetables may be involved with 
specific pathways that affect different cardiovascular disease endpoints. Dietary 
recommendations for the general public to consume at least 5 servings of fruits and vegetables in 
order to decrease risk of CVD were validated. More specifically, increased intake of fruits 
appeared to display greater cardio-protective properties. Thus, further studies on specific fruits 
and vegetables may help elucidate the bioactive ingredients that are responsible for the inverse 
association to chronic diseases. 
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STRAWBERRIES AND CARDIOVASCULAR DISEASE 
EPIDEMIOLOGICAL STUDIES 
 Several epidemiological studies have been conducted on the association of strawberry 
and CVD, markers of CVD, and CVD mortality. Strawberry and specific strawberry flavonoids 
have been associated with a lower risk of CVD and CVD markers (8, 9, 34). In the Women’s 
Health Study, Sesso et al (2007) studied the following: 1) the prospective association of 
strawberry intake and CVD in 38,176 female health professionals and 2) the cross-sectional 
association of strawberry intake with lipids and CRP in 26,966 female health professionals for an 
average of 10.1 years. CVD was defined as confirmed myocardial infarction, stroke, coronary 
artery bypass graft surgery, percutaneous transluminal coronary angioplasty, and cardiovascular 
death. Strawberry intake was evaluated by a 131 item validated semi-quantitative food frequency 
questionnaire. Categories of strawberry consumption were divided into four groups: none, 1-3 
servings/month, 1 serving/week, and ≥2 servings/week. In the prospective study, higher intake of 
strawberry was not associated with risk of CVD (p=0.28) nor was it associated with specific 
cardiovascular endpoints (all p>0.05). At strawberry intake ≥1 serving/week, there was a 
suggestion of lower risk of CVD mortality, but the findings are limited by the low amount of case 
counts. In the cross-sectional study, total- and LDL-cholesterol levels were both modestly lower 
with higher levels of strawberry intake. However, there were no associations between strawberry 
intake and the relative risk of higher plasma lipid levels (p>0.05). 
In addition, after multivariate adjustment, women consuming ≥2 servings/week of 
strawberries had a 14% lower likelihood of having CRP levels ≥3 mg/L (p=0.012). Since CRP is 
negatively associated with strawberry consumption, this may indicate that strawberry intake was 
beneficial in decreasing inflammation. Sesso et al. (2007) may not have found more profound 
associations between strawberry intake and CVD endpoints and markers due to the small degree 
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of differentiation between the low to high strawberry groups. In addition, the high consumption 
group (≥2 servings of strawberries/week) was considerably lower than the United States 
Department of Agriculture (USDA) recommendation of 2 servings of fruits/day. 
 Further epidemiological studies examined the association of specific strawberry 
flavonoids on CVD mortality and incident hypertension (8, 9). In the Iowa Women’s Health 
Study, Mink et al. (2007) examined the prospective cohort association between flavonoids intake 
and CVD mortality in 34,489 postmenopausal women over an average of 16 years. CVD 
mortality was defined as CVD, CHD, stroke, or total mortality. Flavonoid intake was evaluated 
by a 127 item food frequency questionnaire. After simple and multivariate adjustment, 
anthocyanidin intake (0.01-1040 mg/d or 0.03-3099.85 g of raw strawberries) was significantly 
associated with decreased rate of total, CHD, and CVD mortality (p<0.05) compared to no 
anthocyanidin intake.  
In addition to anthocyanins, flavanones were also significantly associated with lower total 
mortality, CHD mortality, and CVD mortality (p<0.05) (8). However, after multivariate 
adjustment, the association of decreased total (p=0.123) and CVD mortality (p=0.054) with 
increased flavanones were less significant. Flavanone concentrations in frozen and raw 
strawberries were considerably less than anthocyanidin concentrations per 100 grams of 
strawberries (6). The median of flavanones in the lowest quintile was 7.6 mg/d, which was 
approximately 2923.08 g of raw strawberries (6). The low concentration of flavanone suggested 
that although there were positive health benefits associated with increased flavanone intake, 
strawberries were most likely not the source of consumption. 
 Mink et al. (2007) also found that individuals who consumed greater than 1 serving of 
strawberries per week had a lower rate ratio of CHD and CVD mortality (p<0.05). Total and 
specific flavonoids intake were not associated with risk of stroke mortality (p>0.05). In this study, 
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there were suggestions that minimal strawberry consumption may be beneficial in lowering risk 
of mortality due to CVD. Further studies on an appropriate dose of strawberries required to 
prevent CVD mortality may be warranted. 
 Cassidy et al. (2011) studied the prospective association of flavonoids subclasses and 
incident hypertension. Subjects were followed for an average of 14 years from the Nurses’ Health 
Study I and II (n=87,242) and Health Professionals Follow-up study (n=23,043). Flavonoid intake 
was calculated from semi-quantitative food-frequency questionnaires. This study found that 
average anthocyanin intake was 12.5-15.2 mg anthocyanins per day and the main sources were 
blueberries and strawberries. The highest quintile of anthocyanin intake was associated with an 
8% lowered risk of hypertension compared to the lowest quintile of anthocyanin intake (p=0.03). 
Additional analysis of participants under the age of 60 years in the highest quintile group 
compared to the lowest quintile group had a 12% reduction in incidence of hypertension 
(p<0.001). This increased protection against hypertension in the younger age group may possibly 
be due to the irreversible damage to endothelial function and blood pressure in older individuals. 
This also suggested the importance of early detection and implementation of dietary intervention 
to control blood pressure. 
However, strawberry intake of >1 serving of strawberries per week was not significantly 
associated with a reduction in hypertension (p=0.34) (9). Although strawberry consumption was 
not associated with significant reduction in hypertension, blueberries displayed a significant 
reduction in hypertension. This suggested that berries may display anti-hypertensive properties. 
Since blueberries have approximately 4-5 times more anthocyanin content per 100 grams than 
strawberries (6), strawberry intake may be too low to exhibit a reduction in hypertension. 
Nevertheless, fruits rich in flavonoids such as anthocyanins may exhibit beneficial effects on 
controlling hypertension. Further clinical research on the appropriate dose of strawberry 
supplementation may help clarify the role of strawberries in reducing CVD risks. 
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CLINICAL STUDIES 
Strawberries on antioxidant capacity and lipid peroxidation 
 Development of many chronic diseases had been attributed to the imbalance of oxidative 
stress products and antioxidants. Under normal physiological conditions, an estimated 1% of 
oxidation products form from mitochondrial electron flow to superoxide (35). The generation of 
this reactive oxygen species in normal cells is typically mediated by endogenous antioxidant 
systems such as glutathione, α-tocopherol, carotenoids, and ascorbic acid (35). However, 
oxidative stress occurs when oxidation products surpass antioxidant systems to attenuate stress. 
Exogenous sources of antioxidants have been evaluated as an intervention to decrease risk of 
chronic diseases. Strawberries have been studied due to their nutrient composition and popularity 
as a fruit. Strawberries contain significant amounts of vitamin C and polyphenols, which have 
been found to have significant antioxidant capacity. Several clinical trials have reported increased 
plasma antioxidant capacity and decreasing oxidative stress products after strawberry 
supplementation. 
In a crossover intervention study by Henning et al. (2010), the impact of strawberry 
consumption on antioxidant capacity was investigated. Twenty one healthy females were 
recruited to consume 250 g of frozen strawberries with breakfast everyday for three weeks. Lipid 
peroxidation lag time increased from baseline in both fasting (25.4±21.0 to 31.5±22.9) and non-
fasting (25.0±19.6 to 31.1±24.9) serum (p<0.05). LDL oxidation lag phase returned to baseline 
levels after washout of three weeks. This 20% increase in lipid peroxidation lag time suggested 
that strawberry intervention positively increased antioxidant capacity in the serum. Henning et al. 
also measured oxidative DNA damage by calculating the ratio of 8-oxo-dG to 106 dG. There was 
a decreasing trend of approximately 1.3 and 0.5 in fasting and non-fasting levels, respectively 
(p=0.12).  These findings suggested that supplementation of 250 g of strawberries everyday for 3 
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weeks decreased oxidative damage most likely from the increase in antioxidant capacity in the 
serum. 
Strawberries on blood pressure, inflammation, & lipids 
In a single-blind, randomized, placebo-controlled intervention, Erlund et al. (2008) 
investigated the effects of berry intervention on hemostatic function, serum lipids, and blood 
pressure (BP) in 72 subjects with CVD risk factors but are otherwise healthy and were not on 
medication. Subjects consumed 100g whole berries and 50 g crushed lingonberries every other 
day and 100 g black currant or strawberry puree and 0.7 mL of cold-pressed chokeberry and 
raspberry juice on the alternative days. The control group consumed 1 of 4 different calorie-
control products each day. Erlund et al. found that blood pressure in the berry group was 
significantly different from control. Systolic blood pressure (SBP) significantly decreased by 1.5 
mmHg in berry intervention and increased by 0.50 in control (p=0.050). Diastolic blood pressure 
(DBP), on the other hand, did not change in the berry intervention but increased by 0.9 mmHg in 
the control intervention (p=0.044). However, additional analysis of baseline BP showed that only 
the highest tertile of SBP was significantly different. In the highest tertile of SBP, there was a 
mean decrease of 7.3 and 0.2 mmHg in berry and control groups, respectively (p=0.024). This 
suggested that berry intervention more powerfully influenced blood pressure in higher ranges. 
In addition, Erlund et al. found no changes in cholesterol and triacyglycerol levels. 
However, HDL cholesterol significantly increased in berry by 5.2% (0.08 mmol/L) compared to a 
0.6% (0.01 mmol/L) increase in control (p=0.006). A positive increase in HDL cholesterol was 
considered positive for cardiovascular health. 
Erlund and colleagues also measured platelet function through the measure of collagen 
and ADP (CADP-CT) time. Supplementation of berries was found to significantly increase 
collagen and ADP (CADP-CT) time by 11% (8.4 seconds) in berries versus a decrease of 1.4% 
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(1.2 seconds) in control (p=0.018). An increase in platelet aggregation time implied that berries 
were positive for cardiovascular health by reducing risk of clotting. 
The results from this study suggested that berries were positive for cardiovascular health 
by exhibiting positive effects of blood pressure, cholesterol, and platelet function. However, the 
study included a mix of various berries; therefore, the individual effects of strawberries cannot be 
teased out. In addition, the dose of strawberry intervention was relatively modest (100g of 
strawberries every other day). Nevertheless, the profound effects on cardiovascular health despite 
the modest dose of berries per day were noteworthy. It also suggested that different types of 
berries, with complementary concentrations of different polyphenols, may have an increased 
benefit compared to consuming a single type of berry. 
Strawberries, lipid profile & lipid peroxidation 
Hyperlipidemia and obesity have been associated with increased risk of developing CVD 
(12, 26, 36). Targeting the decrease of adipocytes and circulating lipids may be beneficial in the 
management of CVD. Dietary management of CVD by increasing strawberry intake has been 
shown to attenuate lipid profile in several clinical studies (37-39). Strawberry intake was found to 
decrease lipid profile in participants at high metabolic risk (37). 
Basu et al. (2009; 2010) conducted two intervention studies on the effects of freeze-dried 
strawberry powder (FSP) supplementation on atherosclerotic markers in subjects with metabolic 
syndrome. The study reported in 2009 was an intervention study without a control group (n=16), 
whereas the study reported in 2010 was a randomized controlled study (n=25). The intervention 
in both studies was 50 g FSP (approximately 500 g fresh strawberries) beverage. The control 
group in the study by Basu et al. (2010) received no intervention but consumed the equivalent 
amount in liquids. 
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 Strawberry supplementation was found to significantly reduce total- and LDL-
cholesterol. After 4 weeks of strawberry supplementation, Basu et al. (2009) found that subjects 
reduced total cholesterol levels from baseline by 5% (5.32 to 5.05 mmol/L) (p<0.05). LDL 
cholesterol also significantly decreased by 6% from baseline (3.2 to 3.0 mmol/L). Similarly, after 
8 weeks of strawberry supplementation, Basu and colleagues (2010) found a significant decrease 
in total- and LDL-cholesterol compared to a non-intervention, liquid volume control. In the 
intervention group, subjects had a mean decrease of 10% in total cholesterol levels from 5.8±0.2 
to 5.2±0.2 mmol/L compared to a non-significant decrease of 0.1 from 5.5 mmol/L in the control 
group. Additionally, subjects significantly lowered LDL cholesterol by 11% from 3.5±0.2 to 
3.1±0.1 mmol/L compared to no change in the control group. Compared to the study from the 
previous year, total- and LDL-cholesterol decreased by approximately twice the percentage and 
also decreased by approximately twice the mmol/L. Since both intervention studies received a 
similar amount of FSP, this suggested that increased duration in strawberry intervention may 
provide additional reduction in total- and LDL-cholesterol. 
After strawberry supplementation in the studies by Basu and colleagues (2009; 2010), 
total cholesterol levels decreased from levels considered “borderline high” to levels considered 
“best” (40). LDL-cholesterol levels stayed at levels categorized as “near ideal” in the study by 
Basu et al. (2009) but decreased from levels considered “borderline high” to levels considered 
“near ideal” in the study by Basu and colleagues (2010). However, since subjects in both studies 
are at risk for CVD, recommended LDL-cholesterol levels for people at risk for heart disease is 
lower. Therefore LDL-cholesterol levels should be reduced further in subjects in both studies in 
order to reduce the risk of heart disease. Although LDL-cholesterol levels did not lower to 
optimal levels for this population, the significant decrease may suggest possible therapeutic 
effects of strawberries at lowering LDL-cholesterol levels in subjects with metabolic syndrome. 
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In a randomized crossover study, Jenkins et al. (2008) found that strawberry 
supplementation maintained a lowered lipid profile in 28 hyperlipidemic subjects on a portfolio 
diet. Subjects in the intervention group were advised to buy and consume 1 lb per 200 kcal of 
fresh strawberries. Control participants received 65 g/d oat bran bread. Strawberry 
supplementation maintained a reduction in LDL cholesterol. However, there were no significant 
differences between strawberry supplementation and substudy baseline (p>0.05). This indicated 
that there were no significant strawberry-related effects on lipid profile. However, lipid 
peroxidation products, measured by thiobarbituric acid-reactive substances, were significantly 
lower in subjects who consumed strawberry supplementation compared to substudy baseline (p < 
0.05). This suggested a protection against oxidative damage of lipids. 
Participants in the studies by Basu et al. (2009;2010) and Jenkins et al. (2008) were 
hyperlipidemic subjects. Hyperlipidemia is a major CVD risk factor. Although participants in all 
three studies were hyperlipidemic, subjects in the study by Jenkins et al. were previously 
maintained on a low-saturated fat therapeutic diet for 2.5 years. Since there was already a marked 
decrease in lipid profile, the low-saturated fat therapeutic diet may have masked any additional 
decreases in lipid levels due to strawberry supplementation. 
The strawberry dose for the study by Basu et al. (2009), Basu et al. (2010), and Jenkins et 
al. (2008) were comparable (454-500 g/day). However, Basu and colleagues prepared the 
strawberry beverage with FSP whereas Jenkins et al. used fresh strawberries. The intervention 
time was also the same in all three studies (4 weeks). 
An inherent limitation of the intervention study by Basu et al. (2009) study was that there 
was no control. However, the study provided important preliminary information which warranted 
further investigation with similar dose, duration, and subject population. A strength in this study 
was that freeze-dried strawberries were more standardized than fresh strawberries purchased from 
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the store. Phytochemicals in strawberries are affected by agricultural systems, processing 
methods, and storage (41-43). FSP was more effective than commercial transfer and storage of 
strawberries in maintaining the integrity of nutrients thus ensured a more standardized product. 
On the other hand, commercially purchased strawberries in the study by Jenkins et al. reflected 
the practical application of including strawberries easily attainable by the general public. A 
criticism of the study by Jenkins et al. was that the compositions of the intervention and control 
diet were not well described. Strawberries and oat bran bread were only described to be similar in 
caloric content. Additionally, oat bran bread was described to contain 2 g of β-glucan, which has 
been shown to reduce total and LDL cholesterol (44). It is unclear whether 454 g/d of 
strawberries deliver similar fiber content to maintain lipid profile or whether the decrease was 
attributed to other factors in the composition of strawberries. Without a clear comparison of the 
relevant macro- and micronutrient of both diets, it is difficult to evaluate the characteristic 
responsible for the changes. 
The high compliance rate for all three studies indicated that incorporating strawberries 
was feasible and largely acceptable by the participants. The palatability rating for strawberries 
were also significantly higher than that for oat bran bread (p<0.001). This again indicated the 
practicality of using strawberries as a dietary intervention. In addition, Basu and colleagues 
(2009;2010) and Burton-Freeman et al. (2010) incorporated strawberries in the form of FSP. This 
illustrated that FSP, which were 10% of the fresh weight of strawberries, can be easily 
incorporated as a beverage. Since fruit juice consumption was a major source of fruit intake in the 
American diet, strawberries introduced as a beverage may increase fruit consumption in the 
United States. 
Strawberries on postprandial metabolism 
Strawberries on postprandial antioxidant capacity 
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In a random sequence crossover control study by Cao et al. (1998), 8 healthy female 
subjects were recruited to study the effects of strawberries, spinach, red wine, or vitamin C on 
serum total antioxidant capacity. Cao et al. found that intake of 240 g of strawberries increased 
total antioxidant capacity. This increase in antioxidant capacity was demonstrated by increase in 
the area under the curve (AUC) in serum and urinary oxygen radical absorbance capacity 
(ORAC) and ferric reducing ability of plasma (FRAP). AUC of ORACPCA and FRAP increased 
by 13% and 10%, respectively, compared to control. Urinary ORAC excretion after consumption 
of strawberries was significantly higher than control (p<0.05) (45). This increase in both serum 
and urinary antioxidant capacity indicated that there was absorption and/or increased production 
of antioxidants as a result of strawberry intake. Cao et al. also found that vitamin C and urate only 
accounted for 8.7% and 39.1% of total antioxidant capacity in plasma after strawberry 
supplementation, respectively. Thus, the remaining 50.5% antioxidant capacity may be 
contributed by other factors such as strawberry polyphenols and endogenous sources of 
antioxidants. This suggested that the composition of strawberries may contain compounds that 
increase antioxidant capacity or compounds that act to increase production of endogenous 
antioxidant sources. 
In addition, further analysis by Paiva et al. (1998) investigated the postprandial plasma 
responses of carotenoids in 7 out of the 8 healthy women in the study by Cao et al. (1998). Five 
beverages were studied but only the spinach beverage had a significant source of carotenoid 
content. Strawberry intervention was expected to produce similar results as the control beverage, 
both which were practically devoid of carotenoids. The control intervention had no significant 
difference in carotenoid levels from baseline. However, strawberry beverage had lower 
postprandial carotenoid concentrations than baseline. At 11 and 15 hours postprandial, most of 
the carotenoids were significantly lower than baseline values (p<0.05). In addition, strawberry 
intervention had significantly lowered LDL cholesterol after 1 hr from baseline (p<0.05). The 
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peak decrease was at 15 hours and after 24 hours returned to levels closer to baseline. LDL 
cholesterol reduced by 14.1% from baseline. It was hypothesized by Paiva et al. that strawberries 
may have played a role in interfering with secretion of carotenoids. Since LDL cholesterol was a 
significant carrier of carotenoids (46), the decrease in LDL cholesterol suggested that alterations 
in carotenoid concentrations were not due to decreases in LDL concentrations. Since carotenoids 
have antioxidant activity, strawberry compounds may be protecting against postprandial 
oxidation by preventing the release of carotenoids from lipoprotein. It can be inferred that 
strawberries were a factor in affecting the metabolism of lipids. Further research on the effects of 
strawberry on carotenoid absorption and secretion may clarify this unexpected finding. Also, 
additional research on the decrease of LDL cholesterol may provide insight on the effects of 
strawberry on lipid metabolism. 
Strawberries on postprandial antioxidant capacity and lipid metabolism 
Clinical studies had found that intake of strawberries alone, with a meal, and with a high 
fat meal challenge increased postprandial antioxidant capacity or decreased oxidative damage 
products. Similar to Cao and colleagues (1998), Prior et al. (2007) found a significant increase in 
antioxidant capacity after strawberry supplementation. Prior et al. (2007) recruited seven healthy 
women to consume two servings of 300g Seascape’ strawberries to determine the postprandial 
changes in antioxidant capacity. Prior et al. found that the AUC of whole plasma ORACFL after 
strawberry supplementation is 4314±1153 µmol TE/L · h, which is a 7.0% increase over baseline 
(p<0.05). 
Prior et al. (2007) found that consumption of strawberries peaked whole plasma ORAC 
1.5 hours postprandial and declined thereafter. However, blood samples were not taken after 4.5 
hours postprandial and whole plasma ORAC also did not return to zero, therefore it is difficult to 
determine the total change in antioxidant capacity after strawberry supplementation. At 4.5 hours, 
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changes in whole plasma ORAC declined to only approximately half of peak levels. Similarly, 
after concurrent intake of strawberries with a control coconut drink, Cao et al. (1998) found that 
the peak level for the percentage change in serum total antioxidant capacity (ORACPCA) is 2 hours 
postprandial. In contrast to the findings by Prior et al (2007), antioxidant capacity returned to 
baseline after 4 hours postprandial. The rise in antioxidant capacity by strawberries was affected 
by foods eaten concurrently. Since intake of foods without antioxidants has been found to 
decrease antioxidant capacity (47), serum antioxidant capacity may have returned to baseline 
more rapidly in the study by Cao et al. (1998) because of the addition of the control meal. This 
suggested the importance of incorporating foods high in antioxidants, such as strawberries, during 
each meal in order to attenuate the postprandial decrease in antioxidant capacity. 
In addition, in a randomized, placebo-controlled, 12-week crossover study by Burton-
Freeman et al. (2010), strawberry supplementation significantly reduced triglyceride and 
oxidized-LDL (ox-LDL) levels compared to control. This study investigated the postprandial 
effects of strawberry supplementation in response to a high fat meal (HFM) challenge 
(approximately 28% fat) in 24 participants with dyslipidemia. Participants 1) at baseline, ingested 
a 10 g freeze-dried strawberries or a macronutrient matched controlled beverage and a HFM and 
2) after 6 weeks of consuming strawberry or control beverage daily, both groups ingested a HFM 
with the control beverage only, without a strawberry beverage. Burton-Freeman et al. (2010) 
found that acute and chronic supplementation of strawberry beverage protects postprandial rise 
after a high fat meal challenge in plasma levels. However, chronic supplementation did not 
change fasting clinical endpoints.  
After consuming a strawberry beverage with a HFM, there was a significant reduction in 
postprandial rise in plasma TG (P=0.005), HDL (P=0.003), and ox-LDL (P=0.0008) compared to 
control. Mean plasma TG were at normal levels (135.7±1.8 mg/dL) in the control group and 
strawberry intervention group (130.8±1.8 mg/dL) (48). According to the American Heart 
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Association (AHA), intensive lifestyle and dietary changes can possibly reduce TG levels up to 
50% (48). Therefore, incorporation of strawberries that were a significant decrease in TG 
concentrations may be beneficial in decreasing CVD risk. Mean plasma HDL levels were 
considered at risk for the control group (44.4±0.2 mg/dL) and the strawberry intervention group 
(43.8±0.2 mg/dL). Although reductions in HDL cholesterol are considered negative to 
cardiovascular health, the mean difference between intervention groups may be statistically 
significant; however, the 0.6 mg/dL difference may be of less biological significance. 
Furthermore, Burton-Freeman et al. (2010) found that after adjustment for the subject’s 
fasting ox-LDL concentrations, mean change in plasma ox-LDL concentration was significantly 
lower in the strawberry intervention group than in the control group. In the strawberry 
intervention group, there was an average decrease of 1.0±1.5 U/L in ox-LDL in the plasma. On 
the other hand, the control group had an average increase of 6.3±1.5 U/L in ox-LDL in the 
plasma. A decrease in ox-LDL may be due to an increase in antioxidant which protected against 
oxidation or a decrease in LDL cholesterol concentrations. On the contrary, Burton-Freeman et al. 
(2010) found a significant increase in LDL cholesterol in the strawberry intervention (p=0.04). 
This small but significant increase of 1.5 mg/dL from 118.4 mg/dL in the control group 
demonstrated that strawberries protected against LDL oxidation without a decrease in LDL 
cholesterol. 
In addition, after 6 weeks of strawberry intervention, postprandial rise in mean 
cholesterol (p=0.0001), LDL (p=0.0002), and TG (p<0.0001) were significantly reduced 
compared to the control intervention. This displayed that chronic consumption of strawberries, 
even if not consumed concurrently with the HFM challenge, will reduce the postprandial rise of 
mean cholesterol, LDL, and TG. This protection against postprandial lipemia was found to be 
independent of changes in fasting lipid levels. 
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The implications of these studies were that the types of foods eaten concurrently with 
strawberries may affect the duration and AUC of postprandial rise and fall of lipids. Further 
studies on the changes of postprandial response to different micro- and macronutrient 
compositions of meals eaten with strawberries may be warranted. Another implication was that 
strawberries incorporated into the daily diet as well as a one-time incorporation with a meal will 
protect against postprandial lipemia and oxidation of LDL without changing fasting plasma 
levels.  This suggested that including strawberries into the diet may be one way of protecting 
against CVD by minimizing the postprandial rise of lipids and oxidation of LDL. These data 
agree with other studies that suggest the positive role of strawberries in cardiovascular health. 
Strawberries on postprandial inflammatory and thrombotic responses 
 In a crossover study by Ellis et al. (2011), strawberry supplementation was found to 
significantly protect against postprandial increases in fibrinolytic and inflammatory factors after 
high carbohydrate/fat (HCF) meal. In this study, 24 overweight subjects consumed strawberry or 
control beverage for 6 weeks to investigate the effects of strawberry consumption on plasma 
glucose and insulin secretions as well as inflammatory and fibrinolytic factors in 1) fasting 
plasma levels and 2) postprandial, after a HCF meal challenge and placebo beverage. The 
strawberry beverage contained 10 g freeze-dried strawberry powder (approximately 100 g fresh 
strawberries) and the control beverage was matched for calories, fat, protein, and carbohydrates. 
The HCF meal with the placebo beverage consisted of 134.3 g of carbohydrate (55.9% of kcals) 
and 30.6 g fat (28.6% of kcals). 
 After 6 weeks of intervention, there were no significant differences in fasting values for 
glucose, insulin, inflammatory and hemostatic factors between strawberry and control beverages 
(p>0.05). However, high sensitive (hs)CRP (p=0.09), interleukin (IL)-1β (p=0.08), and tumor 
necrosis factor (TNF)-α (p=0.07) in the strawberry intervention showed marginal decrease 
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compared to the control group. The marginal decrease found in this study was most likely due to 
the low dose of strawberries. Other studies have observed a difference in oxidative or 
inflammatory stress products after chronic supplementation in doses 2 to 5 times greater than in 
this study (37-39, 49).  
 However, strawberry supplementation with a HCF meal displayed anti-thrombotic and 
anti-inflammatory postprandial response by decreasing plasminogen activatory inhibitor (PAI)-1 
and interleukin (IL) activity. After 6 weeks of strawberry intervention, strawberries significantly 
decreased PAI-1 (p=0.002) and IL-1β (p=0.05) compared to control. Also, IL-6 concentrations 
was found to decrease marginally when controlling for fasting IL-6 concentrations (p=0.07). PAI-
1 is an inhibitor of fibrinolysis (50). An increase in PAI-1 suggested an increase risk for 
thrombosis by inhibiting break down of blood clots (51). IL-1β is a cytokine and a marker for 
inflammation. There were no treatment related differences in postprandial glucose, insulin, 
hsCRP, or TNF-α response (p>0.05). 
 Ellis et al. (2011) added to the continual evidence that strawberries modify response to 
oxidative and inflammatory stress. In this study, strawberries were found to attenuate postprandial 
rise in inflammatory cytokines and pro-thrombotic responses in overweight men and women after 
6 week of daily supplementation. Similar to Burton-Freeman et al. (2010), chronic 
supplementation of strawberries attenuated postprandial responses even in the absence of 
strawberries during that particular meal. In addition, there was only a marginal change in fasting 
levels of inflammatory and oxidative stress markers after chronic supplementation. This displayed 
the protective properties of strawberries in the absence of alterations in plasma concentrations.   
Strawberries on postprandial glucose metabolism 
Postprandial metabolism of glucose has become increasingly important. Impairment in 
postprandial control of serum glucose concentrations appeared to be related to increase risk of 
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CVD (52). Postprandial hyperglycemia has been identified as an independent risk factor for CVD 
(52). Hyperglycemia alters endothelial function, increases thrombosis, and increases adhesion 
molecules (52). Endothelial function is affected by the decrease in nitric oxide (NO), which 
regulates vascular tone. A dysfunction in the vasodilation of the endothelium in combination with 
the increased platelet aggregation may lead to cardiovascular dysfunction (52). Hyperglycemia 
also induces the increase in adhesion molecules, intercellular adhesion molecule (ICAM)-1. 
Increased expression of ICAM molecules have been attributed to the activation of atherosclerosis. 
In addition, excessive postprandial glucose concentrations are toxic and generate oxidative stress 
(53). These cell toxicity and oxidative stress products may increase glycation end-products and 
free radicals that promote atherosclerosis. 
Strawberries in the form of a mixed berry purée had been found to affect the postprandial 
glucose response (54). Törrönen et al. (2009) conducted a randomized, controlled, cross-over 
study on the postprandial effects of a mixed berry purée on plasma glucose in twelve healthy 
subjects. The test meal consisted of 37.5 g of each of the following berries: black currants, 
bilberries, European cranberries, and strawberries (a total of 150 g of berries). The control meal 
had a similar carbohydrate profile as the berry meal with 35 g sucrose, 4.5 g glucoses, and 5.1 g 
fructose. Participants ingested the test meal or control meal after a 12 hour overnight fast and 
blood samples were taken at baseline and at different time points postprandial. Törrönen et al. 
(2009) found that after consuming the berry meal, plasma glucose concentrations peaked at 
approximately 7.4 mmol/l after 45 minutes. The plasma glucose concentration in the participants 
that ingested the control meal peaked at approximately 8.5 mmol/l after 30 minutes postprandial. 
Recommended glucose concentrations are less than 10.0 mmol/L 1-2 hours after a meal (55), 
therefore glucose  concentrations in the participants are within normal range. Although the 
control and berry meal had similar carbohydrate profiles, the control meal elicited a more rapid 
and higher peak in plasma glucose concentration than the berry meal.  
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Polyphenols from berries have been found to inhibit α-glucosidase and α-amylase 
activity, enzymes important in digestion of carbohydrates (56). Specifically, α-glucosidase digests 
sucrose into glucose and α-amylase digests polysaccharides into glucose and maltose (57). Since 
the control meal was comprised of simple sugars, inhibition of α-glucosidase is more likely the 
cause of the decrease in glycemic index in the berry meal. In a study by Kurotobi et al. (2009), 
strawberry jams composed of different ratios of saccharides and fiber were shown to affect 
postprandial glucose response differently. The glycemic index of strawberry jams made from 
differing free sugar concentrations ranged from 17 to 76 (58). Additional studies measuring in 
vivo α-glucosidase activity after berry consumption may confirm the role of polyphenols in 
carbohydrate metabolism. 
Furthermore, Törrönen et al. (2009) found that at 15 and 30 minutes postprandial, the 
berry meal had significantly lowered plasma glucose concentrations than control (p<0.05 and 
p<0.001, respectively). According to the graph, at 15 minutes postprandial, plasma glucose was 
approximately 5.5 mmol/l in the berry purée meal and 6.5 mmol/l in the control meal. And at 30 
minutes postprandial, plasma glucose was an estimated 7.2 mmol/l in the berry purée meal and 
8.5 mmol/l in the control meal. In addition, at 150 minutes postprandial, the berry meal had a 
significantly higher plasma glucose concentration than control (approximately 4.9 mmol/l vs 4.5 
mmol/l, respectively). The differences in glucose concentration at those three time points were 
not due to changes in AUC. Although the AUC tended to be lower after the berry meal than after 
the control meal, this was not found to be significant (p=0.29). This indicated that berry purée 
attenuated postprandial glucose concentrations without decreasing the AUC concentrations of 
glucose. 
 An attenuation of glucose concentrations after a meal may be beneficial in cardiovascular 
health since excessive postprandial glucose can be cytotoxic (59). Excessive and prolonged 
increase in glucose levels can lead to increased protein glycation and increased free radical 
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production (59). This in turn may increase risk of CVD by affecting endothelial function (59). 
The subjects in the study by Törrönen et al. (2009) were healthy and maintained glucose 
concentrations within normal limits; however, foods that attenuate glucose concentrations may be 
more pertinent in participants who have impaired glucose tolerance or diabetes. Therefore, further 
studies on the effects of berries on postprandial glucose may be beneficial in subject populations 
who are at risk for glucose intolerance or diabetes. In addition, further studies on strawberries 
alone may help elucidate the role of strawberries on glucose metabolism.  
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CHAPTER III 
 
 
MATERIALS AND METHODS 
Participants 
Following approval from the Institutional Review Board (IRB), men and women with 
abdominal adiposity and dyslipidemia were recruited from the Clinical Research Center (CRC) at 
Oklahoma University and at the Department of Nutritional Sciences (NSCI) at Oklahoma State 
University through flyers and campus e-mail advertisements. Participants had an initial telephone 
screen and then were scheduled for a screening visit. Subjects were qualified through inclusion 
and exclusion criteria. After qualification, 17 subjects were randomized to match for age and 
gender. Eight subjects were enrolled in the strawberry intervention and 9 subjects were enrolled 
in the control group. 
Inclusion criteria 
Subjects were included based on inclusion criteria: 
1. Abdominal adiposity (men >40 inches, women >35 inches) (60) 
2. Dyslipidemia (two of four criteria: fasting total cholesterol >200 mg/dL, triglycerides 
>150 mg/dL, low density lipoprotein (LDL) –cholesterol >100 mg/dL, or high 
density lipoprotein (HDL)-cholesterol (men <40 mg/dL, women <50 mg/dL) (60) 
3. Normal liver, kidney, and thyroid function tests 
4. Stable multivitamin/mineral supplements or prescription medications (except 
hypolipidemic, hypoglycemic, and steroid agents) will also be included 
5. Males and females 
6. Any ethnic group 
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Exclusion criteria 
Subjects were excluded based on exclusion criteria: 
1. Pre-existing disease (e.g. anemia, cancer, heart disease, diabetes [fasting glucose ≥126 
mg/dL], liver, or renal disorders) 
2. Pregnancy and lactation 
3. Consumption of mega doses of antioxidants/fish oil supplements (>1 g/day) 
4. Consumption of hypolipidemia, hypoglycemic, and steroid medications 
5. Abnormal hemoglobin (Hb) (normal range: 12.0-18.0 g/dL), white blood cell (WBC) 
(normal range: 4.0-11.0 K/mm3), or platelets (140-440 K/mm3) 
6. Hypo/hyperthyroidism (normal range for thyroid stimulating hormone: 0.35-4.940 
uiu/mL) 
7. Abnormal liver enzymes (normal range for aspartate transaminase (AST): 7-40 units/L; 
alanine transaminase (ALT): 10-45 units/L) 
8. Abnormal kidney function (normal creatinine: females: 0.7-1.2 mg/dL; males: 0.8-1.2 
mg/dL; normal blood urea nitrogen (BUN): 1-59 years: 7-18 mg/dL; >59 years: 8-21 
mg/dL) 
9. Smoking and drinking alcohol (>1 oz/day)  
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Methods: Research design 
Subjects identified with abdominal adiposity and dyslipidemia 
 
 
Block Randomization (n=15/group) 
 
 
Fiber/calorie control  FSP* (50 g/day) 
 
 
12-week intervention (2 cups beverage/day) 
 
 
Anthropometrics, blood pressure, and blood draws at screen, 6 weeks, and 12 weeks 
 
 
Subjects come 2-3 days/week to Clinical Research Center/Nutritional Sciences building for 
compliance 
 
 
Subjects compensated $30/week or a total of $360 for 12 weeks 
 
*FSP = Freeze-dried strawberry powder 
 
Intervention and compliance 
Subjects consumed 2 cups of the intervention beverage or control beverage daily for 12 
weeks. The intervention beverage consisted of 50g freeze dried strawberry blended into 2 cups of 
water with splenda (optional) per day. The control beverage consisted of 8 g fiber (dietary 
cellulose + Metamucil), 8 tsp sugar, 2 tsp of strawberry Koolaid©, and 4 drops of red food 
coloring blended into 2 cups of water per day. Nutrition composition of the strawberry and 
control intervention is listed on Table 1. 
All subjects made mandatory visits to the research facilities 2-3 days/week to ensure 
compliance. The remaining quantities of beverages were provided in containers for later 
consumption. Height, weight, blood pressure, and waist circumference were measured by trained 
personnel at the Clinical Research Center (CRC) at Oklahoma University (OU) and at Nutritional 
Sciences building at Oklahoma State University (OSU) at screen, 6 weeks, and at 12 weeks of the 
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study. Blood draws were performed by trained nurses at CRC and by trained phlebotomists at 
Stillwater Medical Center at OSU.  
Dietary analyses 
All subjects were asked to follow their usual diet and lifestyle but refrain from other 
sources of berries and related products while on the study. Subjects also maintained 3-day food (2 
weekday and 1 weekend) records at screen, 6 and 12 weeks of the study. Three day averages of 
micro- and macronutrient intakes were calculated using Food Processor (ESHA Research, Salem, 
OR). If a participant ate a food that was not in the database, an online search of the nutrient 
composition was made or a food with very similar nutrient composition was chosen. 
Clinical variables 
Fasting blood samples, after each draw were immediately sent to OU Medical Center 
laboratory or the Stillwater Medical Center laboratory for comprehensive metabolic panel (CMP) 
including glucose, insulin, glycated hemoglobin, lipid panel, electrolytes, liver, kidney, thyroid 
tests, and complete blood count at each visit. Remaining plasma and serum samples were stored 
at -80ºC for future analyses. 
Biomarkers of oxidative stress 
Plasma concentrations of oxidized-LDL were measured using enzyme-linked 
immunosorbent assay (ELISA) kits (Mercodia, Uppsala, Sweden)) according to the 
manufacturer’s instructions. Lipid peroxidation were measured in serum as malondialdehyde 
(MDA) using a colorimetric assay according to the manufacturer’s protocol (LPO-586TM, Oxis 
Health Products, Inc., Portland, OR). All samples were assayed in triplicates within our 
established inter assay variations of 10% for each variable. 
Statistical analyses 
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Descriptive statistics were used to calculate the frequency, mean, and standard error of 
each parameter. Baseline differences between strawberry intervention and control were assessed 
by independent sample t test. 
Changes in anthropometric measures, blood pressure, serum glucose, insulin, and lipid 
profile between strawberry and control groups were assessed by the differences in measurements 
of each group at baseline, 6 weeks, and 12 weeks. One-way ANOVA test was used to assess 
statistical difference between different time points between strawberry and control intervention. 
Additional analysis of within group changes at different time points were assessed by repeated 
measures ANOVA. Statistical significance was set at P < 0.05. Data are represented as mean ± 
standard error. All statistical analyses were run by SPSS for Windows (version 17.0, SPSS, 
2008). 
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RESULTS 
 A total of 25 participants were screened for the study. Of those subjects, 17 participants 
met the satisfactory inclusion and exclusion criteria and agreed to be enrolled in the study. Eight 
subjects were randomized into the strawberry intervention and 9 subjects were randomized into 
the control intervention. All the subjects who were enrolled completed the 12 week study. In 
addition, 100% of the subjects in both groups adhered to the diet, which was assessed by 
returning bottles empty of research contents to researchers 2-3 times per week. There were no 
complaints from the participants about adverse effects from supplementation. 
No significant differences were found in baseline characteristics between strawberry 
intervention and control (Table 2). 
Anthropometric measures and blood pressure 
 At baseline, anthropometric measures and blood pressure of the strawberry and control 
intervention groups were not statistically different. 
 Anthropometric measures did not significantly change in the strawberry intervention 
group from 0 to 12 weeks (Table 3). Waist circumference significantly decreased by 0.694 inches 
(p=0.015) from 0 to 6 weeks, but increased by 0.712 inches from 6 weeks to 12 weeks (p<0.05). 
However, the net change from 0 to 12 weeks was not significantly different. Similarly, 
anthropometric measures did not significantly change in the control intervention after 12 weeks 
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of supplementation (Table 3). 
 Blood pressure did not significantly change in the strawberry or control group after 12 
weeks supplementation. Between group differences in blood pressure were not statistically 
significant. 
Glucose and insulin 
At baseline, glucose, hemoglobin A1c, and insulin were not significantly different 
between strawberry and control group (p>0.05). 
Fasting glucose, hemoglobin A1c, and insulin did not significantly change in the 
strawberry and control group after 12 weeks supplementation (Table 3). Between group 
differences in glucose, hemoglobin A1c, and insulin were not statistically significant. 
Lipid profile 
Baseline lipid panel between strawberry and control intervention were not statistically 
different. 
Lipid profile did not significantly change in the strawberry and control group after 12 
weeks supplementation (Table 3). Between group differences in lipid panel were not statistically 
significant. 
Biomarkers of lipid oxidation 
In the strawberry group, mean ox-LDL was 133.5 ± 5.1 U/L at baseline (Table 3). After 6 
weeks intervention, ox-LDL decreased significantly from baseline by a mean of 10.4 U/L 
(p=0.011) (Table 5). From 6 weeks to 12 weeks, ox-LDL decreased further by a mean of 3.9 U/L. 
Ox-LDL significantly decreased from baseline to 12 weeks by 10.6% (p=0.004) (Table 5). 
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At baseline, mean ox-LDL was 127.0 ± 5.8 U/L in the control group (Table 3). From 
baseline to 6 weeks of the study intervention, mean ox-LDL significantly decreased by a mean of 
7.1 U/L (p=0.001) (Table 5). From 6 weeks to 12 weeks, ox-LDL decreased further by a mean of 
1.0 U/L. After 12 weeks, ox-LDL significantly decreased by 6.4% compared to baseline 
(p=0.001). 
The between group changes from baseline to 6 weeks, 6 weeks to 12 weeks, and baseline 
to 12 weeks were not statistically different for ox-LDL (p>0.05) (Table 4). However, from 
baseline to 12 weeks, participants who consumed the strawberry supplementation had a 
decreasing trend of ox-LDL concentrations compared to control (p=0.054). 
 In the strawberry group, mean MDA was 3.0 ± 0.22 µM at the beginning of the study 
(Table 3). After 6 weeks of supplementation, MDA significantly decreased by a mean of 0.45 µM 
(p=0.021) (Table 5). After 12 weeks, MDA decreased further by a mean of 0.17 µM from 6 
weeks. At the end of the study, MDA significantly decreased by a total of 23.3% from baseline 
(p=0.007). 
 At baseline, mean MDA was 0.17 ± 0.09 µM in the control group. From 0 weeks to 6 
weeks of the study, MDA significantly decreased by a mean of 0.48 µM (p=0.010) (Table 5). 
However, from 6 weeks to 12 weeks, MDA increased by a mean of 0.07 µM. After 12 weeks, 
MDA significantly decreased by a total of 14.8% (p=0.048). 
 The between group changes from baseline to 6 weeks, 6 weeks to 12 weeks, and baseline 
to 12 weeks were not statistically different for MDA (p>0.05) (Table 4). From baseline to 6 
weeks, MDA decreased in both groups. However, from 6 weeks to 12 weeks, the strawberry 
intervention had a decreasing trend in MDA concentrations compared to control (p=0.093). 
Nevertheless, the summed change in MDA concentrations was not significantly different between 
groups from baseline to 12 weeks. 
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Dietary intake 
 Dietary intake of the strawberry and control group for baseline and 12 weeks were 
presented on Table 6. Nutrient analyses were not statistically different on any of the nutrients at 
baseline and week 12 for the strawberry and control intervention (p>0.05). The baseline dietary 
intake for one participant in the strawberry group was not indicative of usual intake because the 
subject was suffering from gastrointestinal problems unrelated to the study.  
 At week 6, fiber intake in the control group was significantly higher than the strawberry 
group (19.4 ± 5.9 g vs 13.3 ± 1.7 g, respectively) (p=0.036). At week 12, selenium intake was 
significantly higher in the strawberry group than the control group (56.1 ± 9.0 vs 33.7 ± 5.0, 
respectively) (p=0.04). 
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TABLE 1: Composition of strawberries and control beverage 
Nutritive value Freeze-dried strawberries (50g) 1 Control 2 
Calories (kcal) 150 150 
Protein (g) 3.5 - 
Fat (g) 0.5 - 
Carbohydrates (g) 50 - 
Dietary fiber (g) 8 8 
Ash (g) 3.17 - 
Vitamin C (mg) 109 3 
Total Phenolics (mg) 3 2006 - 
Total Anthocyanins (mg) 4 154 - 
Ellagic acid (mg) 41 - 
Phytosterols (mg) 50 - 
1
 Ten percent fresh weight; California Strawberry Commission (Watsonville, CA, USA). 
2
 Fiberstir LLC (Plymouth, MN, USA) 
3 Expressed as milligram gallic acid equivalents 
4 Expressed as milligram cyaniding-3-glucoside equivalents 
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TABLE 2: Baseline characteristics of participants1 
 Strawberry Intervention Control 
n 8 9 
Age (years) 46.5 ± 4.1 51.8 ± 2.8 
Male/Female (n/n) 2/6 1/8 
Waist circumference (inches) 45.3 ± 2.0 41.5 ± 1.0 
BMI (kg/m2) 39.0 ± 2.9 35.6 ± 1.9 
TC(mg/dL) 212.9 ± 11.5 211.7 ± 12.9 
LDL (mg/dL) 140.0 ± 11.9 128.0 ± 10.9 
HDL (mg/dL) 45.1 ± 7.2 46.3 ± 3.2 
TG (mg/dL) 179.9 ± 24.2 185.2 ± 25.5 
Multivitamin users (%) 2.0 1.0 
ALT (IU/L) 24.5 ± 2.6 28.1 ± 2.4 
AST (IU/L) 24.1 ± 1.2 24.0 ± 1.8 
BUN (mg/dL) 13.5 ± 0.6 15.3 ± 1.0 
1Data are means ± standard error. 
Abbreviations: BMI, body mass index; TC, total cholesterol; LDL, low density lipoprotein; HDL, 
high density lipoprotein; TG, triglycerides; ALT, alanine aminotransferase; AST, aspartate 
aminotransferase; BUN, blood urea nitrogen. 
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TABLE 3. Anthropometric measures, blood pressure, glucose control, and lipid panel of participants after 12-wk supplementation with 
freeze-dried strawberries or control treatment1 
Desirable 
Range2 
 
Strawberry Intervention (n=8) Control Intervention (n=9) 
  
  0 week 6 week 12 week   0 week 6 week 12 week 
BMI (kg/m2) 18.5-24.9  39.0 ± 2.9 38.8 ± 2.9 38.9 ± 3.2 35.6 ± 1.9 35.7 ± 2.0 35.6 ± 1.9 
Waist (inches) Men <40 
Women <35 
 45.3 ± 2.0 44.6 ± 1.8 45.3 ± 2.0 41.5 ± 1.0 41.6 ± 1.0 42.1 ± 1.2 
SBP (mmHg) <120  136.5 ± 4.2 134.6 ± 3.7 134.5 ± 5.2 130.8 ± 4.5 131.1 ± 3.9 131.1 ± 3.0 
DBP (mmHg) <80  86.4 ± 3.7 84.9 ± 3.3 84.1 ± 3.5 82.1 ± 1.2 80.8 ± 1.6 93.4 ± 1.6 
Glucose (mg/dL) 90-130  89.5 ± 5.6 95.8 ± 6.5 89.0 ± 5.9 91.0 ± 6.1 98.8 ± 4.6 93.4 ± 6.6 
HbA1c (%) 4.5-6  5.9 ± 0.19 - 5.8 ± 0.31 6.0 ± 0.18 - 5.7 ± 0.14 
Insulin (µU/mL) 5-203  17.7 ± 3.1 18.6 ± 2.6 15.5 ± 3.0 26.4 ± 5.8 20.0 ± 1.4 18.2 ± 2.4 
TC (mg/dL) <200  212.9 ± 11.5 202.0 ± 8.4 201.8 ± 7.3 211.7 ± 12.9 209.4 ± 13.8 213.1 ± 13.9 
LDL (mg/dL) <100  140.0 ± 11.9 128.5 ± 5.8 123.6 ± 8.7 128.0 ± 10.9 128.2 ± 11.7 127.2 ± 11.3 
HDL (mg/dL) Men >40 
Women >50 
 45.1 ± 7.2 43.0 ± 6.3 44.5 ± 4.7 46.3 ± 3.2 44.9 ± 3.4 49.4 ± 3.6 
VLDL (mg/dL) 5-403  35.8 ± 4.8 39.3 ± 3.8 37.4 ± 4.0 37.0 ± 5.1 36.2 ± 6.1 35.7 ± 5.1 
TG (mg/dL) <150  179.9 ± 24.2 195.0 ± 17.4 185.1 ± 
19.6   
185.2 ± 25.5 180.9 ± 30.6 168.6 ± 20.8 
1Data are means ± standard error. 
2Ranges from MayoClinic.com. 
3Ranges from Drugs.com. 
Abbreviations: BMI, body mass index; Waist, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, 
hemoglobin A1c; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein; VLDL, very low density lipoprotein; 
TG, triglycerides. 
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TABLE 4. Change in lipid profile and oxidative stress markers at different time points after 12-wk supplementation of freeze-dried 
strawberries or control treatment1 
∆ (0-6 wk) ∆ (6-12 wk) ∆ (0-12 wk) 
Strawberry 
Intervention Control 
  
Strawberry 
Intervention Control 
  
Strawberry 
Intervention Control 
TC (mg/dL) 10.9 ± 8.3 2.2 ± 6.7 0.25 ± 5.9 -3.7 ± 8.4 11.1 ± 8.9 -1.4 ± 12.1 
LDL (mg/dL) 11.5 ± 8.8 -0.22 ± 8.0 4.9 ± 7.9 1.0 ± 5.1 16.4 ± 11.1 0.78 ± 9.2 
HDL (mg/dL) 2.1 ± 2.6 1.4 ± 1.6 -1.5 ± 2.1 -4.6 ± 2.7 0.63 ± 3.2 -3.1 ± 3.7 
VLDL (mg/dL) -3.5 ± 3.3 0.78 ± 4.0 1.9 ± 2.9 0.56 ± 3.3 -1.6 ± 3.2 1.3 ± 2.8 
Ratio LDL:HDL 0.14 ± 0.20 -0.13 ± 0.12 0.36 ± 0.14† 0.11 ± 0.19 0.5 ± 0.26 -0.02 ± 0.19 
TG (mg/dL) -15.1 ± 16.7 4.3 ± 20.9 9.9 ± 15.1 12.3 ± 17.6 -5.3 ± 16.5 16.7 ± 11.3 
OX-LDL (ng/mL) 10.4 ± 2.4 7.1 ± 1.1 3.9 ± 1.7 1.0 ± 1.6 14.3 ± 2.7† 8.1 ± 1.3 
MDA (uM) 0.45 ± 0.12 0.48 ± 0.12 0.17 ± 0.09 -0.07 ± 0.15 0.63 ± 0.13 0.41 ± 0.13 
1Data are means ± standard error. 
† Trend, 0.05 < P < 0.1 difference compared to control. 
Abbreviations: TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein; VLDL, very low density lipoprotein; 
TG, triglycerides; OX-LDL, oxidized low density lipoprotein; MDA, malondialdehyde.
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TABLE 5: Repeated measures ANOVA comparison of within groups at 0 week, 6 weeks, and 12 weeks1 
 Strawberry Intervention Control 
OX-LDL (ng/mL) 
    0 Week 133.5 ± 5.1a 127.0 ± 5.8a 
    6 Weeks 123.1 ± 4.2b 119.9 ± 5.9b 
    12 Weeks 119.3 ± 3.4b 118.9 ± 6.1b 
MDA (uM) 
    0 Week 3.0 ± 0.22a 2.7 ± 0.18a 
    6 Weeks 2.5 ± 0.14b 2.2 ± 0.16b 
    12 Weeks 2.3 ± 0.13b 2.3 ± 0.17b 
1 Data are means ± standard error. 
*Values in the same column with different superscripts are significantly different for each set of observations (p<0.05). 
Abbreviations: OX-LDL, oxidized lipoprotein; MDA, malondialdehyde. 
No differences between times within groups on cholesterol, triglycerides, LDL, HDL, and LDL:HDL. 
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TABLE 6. Nutrient analysis of dietary intake at 0 week and 12 weeks 
 
0 week 
 
12 weeks 
 
Strawberry 
Intervention Control   
Strawberry 
Intervention Control 
Calories (kcal) 1716.6 ± 345.8 1949.0 ± 146.2 
 
1786.3 ± 151.1 1809.2 ± 100.8 
Protein (g) 72.6 ± 13.0 66.5 ± 5.6 
 
83.3 ± 14.4 67.7 ± 7.7 
Carbohydrates (g) 196.7 ± 43.6 238.5 ± 20.7 
 
202.4 ± 23.4 202.2 ± 8.2 
Fiber (g) 14.3 ± 1.8 16.7 ± 2.3 
 
16.6 ± 2.1 16.6 ± 2.1 
Fat (g) 70.4 ± 16.7 84.5 ± 6.5 
 
73.5 ± 6.4 79.5 ± 6.4 
    Saturated Fat (g) 21.4 ± 4.9 24.7 ± 2.5 
 
21.5 ± 2.7 27.6 ± 3.2 
    Monounsaturated Fat (g) 14.5 ± 4.2 17.4 ± 3.5 
 
13.8 ± 2.9 16.5 ± 2.1 
    Polyunsaturated Fat (g) 7.6 ± 2.5 10.7 ± 1.1 
 
7.7 ± 1.7 8.6 ± 1.0 
Total Cholesterol (mg) 208.2 ± 41.2 209.3 ± 19.9 
 
175.2 ± 36.3 238.0 ± 45.3 
A-RAE (µg) 566.2 ± 175.3 323.2 ± 109.9 
 
384.7 ± 174.5 359.3 ± 68.1 
Vitamin C (mg) 101.8 ± 38.8 50.6 ± 10.9 
 
73.6 ± 15.2 59.2 ± 15.9 
EToco (mg) 2.6 ± 0.52 7.0 ± 2.0 
 
4.1 ± 1.4 4.4 ± 1.1 
Folate (µg) 231.4 ± 55.5 349.3 ± 138.0 
 
213.3 ± 35.1 245.0 ± 61.7 
Calcium (mg) 758.1 ± 243.0 575.3 ± 90.4 
 
613.7 ± 152.4 646.0 ± 46.0 
Copper (mg) 0.61 ± 0.19 0.63 ± 0.11 
 
0.67 ± 0.09 0.57 ± 0.09 
Iron (mg) 10.8 ± 1.5 12.8 ± 2.6 
 
10.5 ± 0.85 15.6 ± 2.5 
Selenium (µg) 55.2 ± 16.1 36.9 ± 6.4 
 
56.1 ± 9.0* 33.7 ± 5.0 
Zinc (mg) 5.9 ± 1.5 6.8 ± 1.9   6.8 ± 1.2 5.7 ± 0.9 
1
 Data are means ± standard error. 
Abbreviations: RAE, retinol activity equivalents; EToco, tocopherols. 
* Significantly different than control at p=0.04 
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CONCLUSION 
Our study showed a significant decrease in baseline ox-LDL and MDA from 6 weeks and 
12 weeks after strawberry and control intervention. Ox-LDL also showed a decreasing trend after 
12 weeks of strawberry supplementation compared to control. In this 12 week study in subjects 
with dyslipidemia and abdominal adiposity, strawberry beverage did not significantly change 
anthropometric measures, blood pressure, glucose, insulin, lipid panel, and biomarkers of lipid 
oxidation compared to a fiber-control beverage. 
Different forms of strawberries that have been used in different clinical trials are freeze-
dried, frozen, fresh, jam, and puréed. Of the 12 clinical trials that were reviewed, 4 studies 
similarly used freeze-dried strawberry powder (37, 38, 50, 61), 1 study used frozen strawberries 
(49), 4 studies used fresh strawberries (39, 45, 47, 62), 1 study used strawberry jams (58), and 2 
studies used a mix of different berries (63, 64). The fresh strawberry equivalent for the doses used 
in the studies using FSP, frozen strawberries, and fresh strawberries were 100-500 g, 250 g, 250-
454 g, respectively. The dose in the study using strawberry jams was 20 g jam. In the two 
previous studies that used mixed berries, 150-160 g of berries were consumed, where 100 g of 
strawberry purée was consumed every other day in one study and the second study used 37.5 g of 
strawberries per day. Therefore, the dose of strawberries in our study is greater or equal to that 
used in previous studies. 
Since freeze-dried powder (FSP) strawberries are approximately 10% of the fresh 
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strawberry weight, FSP allows for larger doses of strawberries to be consumed per day and is also 
a concentrated source of strawberry polyphenols and fiber. In previous clinical trials, the fresh 
weight equivalent of various forms of strawberries used ranged from 100 g to 500 g. According to 
the USDA MyPlate.gov, men and women 19-50 years of age require 1.5-2 cups of fruits per day. 
50 grams of FSP strawberries or 500 g of fresh strawberries used in our study equate to 
approximately 3.5 cups of strawberries per day. This is well within the appropriate 
recommendation for fruit consumption per day. 
In our study, the intervention was longer than previous long term studies involving 
strawberry supplementation (12 weeks vs 3-8 weeks, respectively). There were also multiple time 
points at baseline, 6 weeks, and 12 weeks in order to better assess the changes in each participant. 
Strawberries on anthropometrics and blood pressure 
 Anthropometric measures did not significantly change from baseline to 12 weeks. Similar 
to other studies, body weight, waist circumference, and BMI did not change after long term 
strawberry intervention (37-39, 64). 
However, in contrast to the null finding on blood pressure in this study, in a study by 
Erlund et al. (2008) berry supplementation has been shown to significantly decrease systolic 
blood pressure (SBP) in healthy subjects with cardiovascular disease (CVD) risk factors 
compared to calorie control (64). There may be multiple explanations for this difference in 
finding. First of all, Erlund and colleagues used a blend of berries rather than an isolated species 
of berry. The varying concentrations of different polyphenols may be working synergistically in 
the biological system to decrease blood pressure. Secondly, the control in the study by Erlund et 
al. was a calorie control whereas the control in our study was a fiber and calorie matched control. 
According to a meta-analysis of the relationship between dietary fiber and blood pressure, 
increasing dietary fiber, where levels are below recommendations, decreases both systolic and 
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diastolic blood pressure (65).  Therefore, there may not have been any differences between 
groups due to the blood pressure lowering effects of fiber. In addition, the sample size in the 
study by Erlund and colleagues were approximately four times the size of the sample size in our 
study. Lastly, although subjects in both studies were pre-hypertensive, subjects in our study have 
higher BMIs and abdominal adiposity compared to the subjects in the study by Erlund and 
colleagues. Subjects in our study were obese whereas subjects in the study by Erlund et al. were 
at the cusp between normal and overweight. Since obesity and abdominal adiposity are 
independent risk factors for developing hypertension (66), the increased metabolic stress may 
require interventions closer to pharmacological doses in order to elicit a change in blood pressure. 
Strawberries on glucose and insulin 
 In our study, strawberry supplementation did not significantly affect glucose, hemoglobin 
A1c, and insulin concentrations. In a study by Torronen et al. (2009), berry supplementation did 
not change the postprandial area under the curve response of serum glucose. However, berry 
supplementation was found to attenuate the spiked glucose response after a meal. This may 
suggest that strawberries may attenuate postprandial rise in serum glucose without changing 
overall glucose concentrations. A decrease in hemoglobin A1c may suggest a decrease in mean 
serum glucose levels over the course of the study. However, the non-significant small decrease 
and large variation limits the interpretation of these numbers. More importantly, glucose and 
hemoglobin A1c levels were within desirable ranges (67), a significant decrease in glucose 
control would not be beneficial to subjects. 
Strawberries on lipid profile 
 In our study, we found that within group and between groups changes in lipid profile 
were not significantly different after strawberry supplementation. Although total cholesterol (TC) 
did not significantly decrease from baseline nor were there significant between group changes, it 
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decreased by a mean of 11.1 mg/dL in the strawberry group, which may have possible biological 
significance. Although not significant, mean TC reduced to levels close to ideal (mean T=201.8 
mg/dL vs ideal <200 mg/dL) . Similarly, although there were no significant decrease from 
baseline nor significant between group changes, LDL cholesterol reduced by 16.4 mg/dL in the 
strawberry intervention group after 12 weeks supplementation. The baseline LDL levels were 
“borderline high” but after 12 weeks supplementation are “near ideal” (67). Although not 
statistically significant, the reduction in LDL in the strawberry group compared to little change in 
the control group may have been significant if given a larger sample size. In addition, the positive 
change in categorization of LDL cholesterol concentrations may suggest positive biological 
effects after chronic consumption of strawberries.   
In other clinical studies, the effects of chronic strawberry supplementation on lipid profile 
have been conflicting. In one study, berry supplementation did not significantly affect total 
cholesterol and triglycerides, but HDL concentrations significantly increased compared to control 
(64). The strawberry dose in that study was relatively small compared to the dose used in our 
study (160 g berries vs ~500 g fresh equivalent, respectively). However, the study participants 
were given a mixture of four types of berries rather than a single dose of strawberries. The 
positive effects on HDL from the modest intake of berries may be due to the interaction from the 
different sources of berries. In another study, supplementation of 454 g of fresh strawberries did 
not significantly change total cholesterol, LDL, HDL, triacylglycerols, and ratio of LDL/HDL 
compared to a fiber control (39). Although the form of strawberries was different, the dose was 
comparable to our study. Subjects in that study were also hyperlipidemic, which is similar to 
subjects in our study. In addition, the control was also an intervention that consisted of fiber. 
In contrast, in two clinical studies, total cholesterol and LDL cholesterol were found to 
significantly decrease from baseline (37, 38). In addition, total cholesterol and LDL cholesterol 
were significantly different from a non-intervention control (38). In our study, there were 
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preliminary data that suggested a mean decrease from baseline in total and LDL cholesterol after 
12 weeks of strawberry supplementation; however, changes did not reach statistical significance. 
The baseline characteristics of the study participants in all three studies are comparable. In the 
two clinical trials, subjects had metabolic syndrome. Similarly, participants in our study have two 
or more (out of the three criteria) that defines metabolic syndrome. The dose and form of the 
strawberry intervention in all three studies is also the same (50 g FSP). The duration is three times 
longer in our study than in the two clinical trials. Since the subject baseline characteristics, dose 
and form of intervention are comparable or the same, the conflicting results in our study from the 
study by Basu et al. (2009; 2010) is most likely due to the small sample size and large variation 
between participants in our study. Nevertheless, the effects of strawberries on lipid panel appear 
to be conflicting between clinical trials. Larger clinical trials on different subject populations and 
comparable control groups may help elucidate the effects of strawberry supplementation on 
serum lipids. 
Strawberries on biomarkers of lipid oxidation 
 In this study, ox-LDL and MDA significantly decreased from baseline but there were no 
significant differences between intervention groups. In addition, the reduction in ox-LDL after 12 
weeks supplementation had a decreasing trend in the strawberry compared to control (p=0.054). 
Oxidized-LDL is pertinent in the progression and exacerbation of atherosclerosis, therefore, a 
decreasing trend in ox-LDL may be protective in the prevention of atherosclerosis. Since ox-LDL 
had a decreasing trend in the strawberry group, an increase in sample size may provide for better 
statistical analysis to find the possible differences between groups. 
In previous studies, strawberry anthocyanins have been found to increase antioxidant 
capacity and decrease lipid oxidation (37, 39, 49). However, a previous epidemiological study has 
also found that an increase in dietary fiber has been associated with a reduction in C-reactive 
51 
 
protein (CRP), a stable marker of inflammation (68). Inflammation and oxidative stress can 
mutually trigger the other so a decrease in inflammation may lead to a decrease in oxidative 
stress. This may explain why the fiber-calorie control also found a significant decrease in lipid 
oxidation products from baseline. However, epidemiological studies cannot eliminate the 
possibility that foods high in dietary fiber contain confounding components such as 
phytochemicals that may have antioxidant and anti-inflammatory properties. Fiber has also been 
shown to decrease lipid profile {Anderson, 1987 #308}, which may indirectly reduce lipid 
oxidative products. However, our study does not indicate a significant change in lipid panel in 
either strawberry or control group. 
 In one study, oxidative damage to LDL, as measured by thiobarituric acid-reactive 
substances, decreased significantly compared to fiber and calorie control (39). Therefore, there is 
suggestion that strawberry supplementation may have additional antioxidant benefits in addition 
to its fiber content.  
Dietary intake 
 Although there may have been a statistical significance in fiber and selenium intake 
between groups at different time points, the biological significance of this difference is in 
question. Since the macro- and micronutrient intake of the participants ranged widely and the 
accuracy and amount of detail each participant chose to record their 3 day recall varied, the 
statistical significance in the differences in dietary intake may have minor biological significance. 
In addition, the nutrient analysis of certain items had to be manually inputted through internet 
searches of the item, and therefore may contain an insufficient database on the content of 
selenium. Since the accuracy of dietary analyses increases with larger sample size, the number of 
subjects in this study may not be sufficient in finding statistical and biological significance in the 
differences in dietary intake. 
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Limitations 
 One major limitation in this current study is the small sample size. Based on two pilot 
studies by Basu and colleagues (37, 38) the sample size of at least 15 subjects per group is 
required to detect 21.8% difference in total cholesterol and 30.6% difference in LDL-cholesterol 
at a significance level of 5% with an 80% power. However, in the current analyses, there are only 
8 and 9 subjects for the strawberry and control group, respectively. 
Another limitation, which is linked to the small sample size, is the large variation 
between participants. The increased deviation between subjects in conjunction with the small 
sample size increases the variability and therefore decreases the likelihood of finding significant 
results. In one instance, the body mass index of subjects in the study ranges from 29 to 52 kg/m2. 
Subjects who are at the cusp of overweight and obese compared to subjects who are well above 
the BMI for extreme obesity may have different metabolic stresses and therefore increased 
dietary intake of fruits, such as strawberries, may see less effect. Larger clinical trials on 
strawberry supplementation will help clarify the degree to which dietary interventions may 
attenuate metabolic stress. 
Although freeze-dried strawberries are a more standardized product compared to fresh 
strawberries, it raises a caveat in our study in its ability to generalize the results. Since freeze-
dried strawberry powder (FSP) is used and purchased for research purposes only, whether FSP 
and commercial strawberry products are similar on its effects on lipid profile and products of 
lipid oxidation are in question. Further studies on the effects of fresh or frozen strawberries on 
metabolic stress may be warranted. 
Conclusion 
In our study, freeze-dried strawberry and fiber-calorie control supplementation 
significantly decreased markers of lipid oxidation compared to baseline. We found no differences 
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between intervention groups for anthropometric measures, blood pressure, glucose, insulin, lipid 
profile, and markers of lipid oxidation. However, strawberry supplementation had a decreasing 
trend of ox-LDL compared to control. Based on our study, supplementation of strawberries as a 
therapeutic intervention to decrease lipid profile is not warranted. However, there has been a 
recent emergence of the antioxidant capacity of strawberries in other studies. If our study had a 
larger sample size, the reduction in ox-LDL may have provided more significant evidence in the 
ability of strawberries to reduce lipid oxidation. Nevertheless, fruit consumption, particularly 
those rich in antioxidants, such as berries, have been found to have cardio-protective properties in 
other clinical and epidemiological studies. Therefore, increasing berry consumption should be 
encouraged, especially in populations with low fruit and vegetable intake and high risk of 
cardiovascular disease. 
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